Related Experiment Video
Updated: Aug 7, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation
Ji-Hyun Chung1, Michael C Ostrowski, Todd Romigh
1Human Cancer Genetics Program, Comprehensive Cancer Center, Department of Molecular and Cellular Biochemistry, Division of Human Genetics, The Ohio State University, Columbus, USA.
Abstract:
PTEN, a tumor suppressor phosphatase that dephosphorylates both protein and lipid substrates, is mutated in both heritable and sporadic breast cancer. Until recently, PTEN-mediated cell cycle arrest and apoptosis were thought to occur through its well-documented cytoplasmic activities. We have shown that PTEN localizes to the nucleus coincident with the G0-G1 phases of the cell cycle and that compartmentalization may regulate cell cycle progression dependent upon the down-regulation of cyclin D1. However, the mechanism for cyclin D1-dependent growth suppression by nuclear PTEN has remained largely undefined. Utilizing MCF-7 Tet-Off breast cancer cell lines stably expressing two different nuclear localization defective PTEN mutants, as well as wild-type PTEN and empty vector control cells, we demonstrate that nuclear PTEN down-regulates cyclin D1 transcription and this event is mediated by the down-regulation of MAPK specifically by nuclear localized PTEN. These results provide further evidence that nuclear PTEN plays a role through cell cycle suppression functions in regulating carcinogenesis.
Insights
Nuclear PTEN, a tumor suppressor, halts breast cancer cell growth by down-regulating cyclin D1 transcription. This process involves the mitogen-activated protein kinase (MAPK) pathway, highlighting nuclear PTEN
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- PTEN is a critical tumor suppressor gene frequently mutated in breast cancer.
- PTEN's cell cycle arrest and apoptosis functions were primarily attributed to its cytoplasmic activities.
- Nuclear localization of PTEN and its role in cell cycle regulation remained largely undefined.
Purpose of the Study:
- To elucidate the mechanism by which nuclear PTEN suppresses cell growth.
- To investigate the role of nuclear PTEN in regulating cyclin D1 transcription.
- To determine the involvement of the MAPK pathway in nuclear PTEN-mediated growth suppression.
Main Methods:
- Utilized MCF-7 Tet-Off breast cancer cell lines.
- Employed stable expression of wild-type PTEN, nuclear localization-defective PTEN mutants, and empty vector controls.
- Assessed PTEN localization, cyclin D1 transcription, and MAPK signaling.
Main Results:
- Demonstrated that nuclear PTEN down-regulates cyclin D1 transcription.
- Showed that nuclear PTEN specifically down-regulates MAPK.
- Confirmed that nuclear localization is essential for PTEN's growth suppression activity via cyclin D1 and MAPK pathways.
Conclusions:
- Nuclear PTEN plays a significant role in cell cycle suppression.
- The down-regulation of cyclin D1 transcription by nuclear PTEN is mediated through MAPK signaling.
- These findings provide evidence for nuclear PTEN's function in regulating carcinogenesis through cell cycle control.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation

